Event-Driven Stocks

LENZ Therapeutics, Inc.

LENZNasdaq

Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 3 good● 3 warningdetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$19.1M$0————
Operating income−$91.1M−$58.6M−$72.4M−$105.6M−$60.4M−$13.5M
Net income−$82.1M−$49.8M−$70.0M−$101.1M−$70.8M−$68.4M
Total assets$305.9M$215.3M$70.4M$321.9M$402.0M$22.6M
Total liabilities$21.5M$11.2M$19.7M$25.6M$17.9M$32.4M
Equity$284.3M$204.1M−$92.7M−$24.2M$384.1M−$65.4M
EPS (diluted)$-2.85$-2.34$-35.71$-1.84$-2.45—
Shares out.27.5M58.2M58.2M58.0M58.0M10.3M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−477.5%
Net margin
−430.3%
Return on equity
−28.9%
Return on assets
−26.8%
Return on capital (ROCE)
−32.0%
Liabilities / assets
7.0%
Debt / equity
0.08×
Book value / share
$10.32
Revenue growth (YoY)
—
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
15.45safe
Accruals / assets
−4.2%clean
Piotroski F-Score
3/8weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
59
/ 100
Profitability 0Growth n/aCatalyst 67Earnings quality 67Financial strength 100

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →

Signs

● 3 warning● 3 good
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Negative operating cash flow
  • Conservative leverage (liabilities < 50% of assets)
  • Clean earnings (low accruals)
  • Altman Z″ in the safe zone

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 202611.1M11.0+3.5%
Apr 30, 202610.7M14.2+13.2%
Apr 15, 20269.5M13.9+4.9%
Mar 31, 20269.0M5.9-6.0%
Mar 13, 20269.6M14.1+8.0%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (2)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.